DKCM
CNLM

Davidson Kempner Capital Management’s CB PHARMA ACQUISISTION CORP SHS (CYM) CNLM Stock Holding History

Davidson Kempner Capital Management’s Portfolio CNLM Stock Details CNLM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-350,000
Closed -$3.54M – 193
2016
Q1 		$3.54M Buy
+350,000
New +$3.5M 0.08% 120

Davidson Kempner Capital Management's CNLM Position: Q2 2016 in Review

Davidson Kempner Capital Management sold out of CB PHARMA ACQUISISTION CORP SHS (CYM) (CNLM) in Q2 2016, closing a stake of 350,000 shares — an estimated $3.54M sold.

Davidson Kempner Capital Management first reported a position in CNLM in Q1 2016 and held it in 1 quarter. The position peaked at $3.54M in Q1 2016. 0 funds tracked by Wall St. Rank hold CNLM as of Q2 2016.

  • Davidson Kempner Capital Management reported no remaining CB PHARMA ACQUISISTION CORP SHS (CYM) position as of Q2 2016 after selling out during the quarter.
  • Davidson Kempner Capital Management sold 350,000 CB PHARMA ACQUISISTION CORP SHS (CYM) shares in Q2 2016, an estimated $3.54M.
  • Davidson Kempner Capital Management first reported a position in CB PHARMA ACQUISISTION CORP SHS (CYM) in Q1 2016 and held it in 1 quarter.
  • Davidson Kempner Capital Management's CB PHARMA ACQUISISTION CORP SHS (CYM) position peaked at $3.54M in Q1 2016.
  • 0 funds tracked by Wall St. Rank held CB PHARMA ACQUISISTION CORP SHS (CYM) as of Q2 2016.

Based on Davidson Kempner Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.